LTFS
TXMD icon

Ladenburg Thalmann Financial Services’s TherapeuticsMD TXMD Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$22K Sell
33
-358
-92% -$51.5K ﹤0.01% 4107
2019
Q3 		$71K Buy
391
+6
+2% +$846 ﹤0.01% 3185
2019
Q2 		$51K Buy
385
+4
+1% +$717 ﹤0.01% 3454
2019
Q1 		$92K Hold
381
– – ﹤0.01% 2943
2018
Q4 		$72K Sell
381
-190
-33% -$46.3K ﹤0.01% 2996
2018
Q3 		$187K Sell
571
-20
-3% -$6.13K ﹤0.01% 2361
2018
Q2 		$143K Hold
591
– – ﹤0.01% 2490
2018
Q1 		$143K Sell
591
-18
-3% -$5.05K ﹤0.01% 2490
2017
Q4 		$184K Buy
609
+120
+25% +$33.4K ﹤0.01% 2267
2017
Q3 		$129K Sell
489
-14
-3% -$4.05K ﹤0.01% 2432
2017
Q2 		$132K Buy
503
+40
+9% +$10K ﹤0.01% 2336
2017
Q1 		$167K Buy
463
+20
+5% +$6.19K ﹤0.01% 2046
2016
Q4 		$128K Buy
443
+75
+20% +$23.2K ﹤0.01% 2129
2016
Q3 		$126K Buy
368
+41
+13% +$15K ﹤0.01% 2080
2016
Q2 		$139K Sell
327
-86
-21% -$35.4K ﹤0.01% 1919
2016
Q1 		$132K Sell
413
-52
-11% -$17.7K ﹤0.01% 1883
2015
Q4 		$241K Sell
465
-115
-20% -$42.5K ﹤0.01% 1456
2015
Q3 		$170K Sell
580
-6
-1% -$2.13K ﹤0.01% 1597
2015
Q2 		$230K Buy
586
+20
+4% +$7.06K ﹤0.01% 1513
2015
Q1 		$180K Buy
566
+26
+5% +$6.35K ﹤0.01% 1649
2014
Q4 		$120K Buy
+540
New +$111K ﹤0.01% 1782

Other funds holding TXMD

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ladenburg Thalmann Financial Services's TXMD Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its TherapeuticsMD (TXMD) stake by 92% in Q4 2019, selling an estimated $51.5K and leaving 33 shares worth $22K. The position accounts for ﹤0.01% of the portfolio, ranked #4107.

Ladenburg Thalmann Financial Services first reported a position in TXMD in Q4 2014 and has held it in 21 quarters since. The position peaked at $241K in Q4 2015. 168 funds tracked by Wall St. Rank hold TXMD as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 33 shares of TherapeuticsMD worth $22K as of Q4 2019.
  • Ladenburg Thalmann Financial Services sold 358 TherapeuticsMD shares in Q4 2019, an estimated $51.5K.
  • TherapeuticsMD made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4107 holding.
  • Ladenburg Thalmann Financial Services first reported a position in TherapeuticsMD in Q4 2014 and has held it in 21 quarters since.
  • Ladenburg Thalmann Financial Services's TherapeuticsMD position peaked at $241K in Q4 2015.
  • 168 funds tracked by Wall St. Rank held TherapeuticsMD as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.